PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Clinical trials: two arms are better than one

In a comment to the EMA, IQWiG emphasizes that single-arm studies may be sufficient for drug approval in exceptional cases - but not for HTA. They hinder rather than accelerate improvements in health care

2023-10-06
(Press-News.org) The German Institute for Quality and Efficiency in Health Care (IQWiG) has responded critically to a reflection paper by the European Medicines Agency (EMA) on the approval of new drugs based on single-arm studies. The EMA correctly points out that studies without a control arm are subject to bias and that, in general, it is hardly possible to estimate causal effects from them. However, it does not provide clear criteria for limiting drug approval based on such studies to extremely rare exceptional cases.

The FDA shows how to do it There is also no recommendation on external controls - in contrast to guidance published in February by the US Food and Drug Administration (FDA).

Beate Wieseler, Head of IQWiG’s Drug Assessment Department notes: "The FDA clearly states that the likelihood of demonstrating the effectiveness of a drug with an external control is low, and strongly recommends a study design with an internal control - also for rare diseases. In addition, the FDA designates specific situations where externally controlled studies are generally not suitable, for example when the natural history of the disease is not well known or the disease course is variable. The EMA should include these points in its reflection paper.”

Accelerated approval is not an end in itself The situation is well known: in rare cases, single-arm studies can demonstrate the safety and efficacy of a new drug well enough to gain regulatory approval. But when it comes to its actual use in a health care system, the drug needs to be compared with existing treatment options - and this should happen as quickly as possible.

Beate Wieseler explains: "By publicly reflecting on the opportunities and limitations of single-arm studies for approval, without describing consequences of their drawbacks, the EMA is doing a disservice to both drug companies and patients. Drug development is efficient when new drugs can be used immediately and appropriately in health care. To achieve this, studies should be conducted from the outset that are suitable both for approval and for integration into the health care landscape through health technology assessment (HTA). This is not about accelerating market access for new drugs per se, but about accelerating their evidence-based introduction into the health care system - for the benefit of patients.”

END


ELSE PRESS RELEASES FROM THIS DATE:

The efficient perovskite cells with a structured anti-reflective layer – another step towards commercialization on a wider scale

The efficient perovskite cells with a structured anti-reflective layer – another step towards commercialization on a wider scale
2023-10-06
Perovskite-based solar cells, widely considered as successors to the currently dominant silicon cells, due to their simple and cost-effective production process combined with their excellent performance, are now the subject of in-depth research. A team of scientists from the Fraunhofer Institute for Solar Energy ISE and the Faculty of Physics at the University of Warsaw presented perovskite photovoltaic cells with significantly improved optoelectronic properties in the journal Advanced Materials and Interfaces. Reducing optical losses in the ...

BU researcher awarded $3.7 million to study how endothelial cell health impacts disease

2023-10-06
(Boston)—Naomi Hamburg, MD, the Joseph A. Vita Professor of Medicine at Boston University Chobanian & Avedisian School of Medicine, has been awarded a five-year, $3.7 million grant from the National Heart, Lung and Blood Institute for her research study, “Endothelial Cell Health Across the Spectrum of Cardiometabolic Disease.”   Cardiometabolic diseases are a group of common but often preventable conditions including heart attack, stroke, diabetes, insulin resistance and non-alcoholic fatty liver disease. The escalating prevalence of cardiometabolic risk factors including obesity and type 2 diabetes mellitus (T2DM) ...

Autoimmune and autoinflammatory connective tissue disorders following COVID-19

2023-10-06
About The Study: COVID-19 was associated with a substantial risk for autoimmune and autoinflammatory connective tissue disorders in this retrospective cohort study, indicating that long-term management of patients with COVID-19 should include evaluation for such disorders.  Authors: Solam Lee, M.D., Ph.D., of Yonsei University Wonju College of Medicine in Wonju, Republic of Korea, is the corresponding author.   To access the embargoed study: Visit our For The Media website ...

Cancer research: Metabolite drives tumor development

Cancer research: Metabolite drives tumor development
2023-10-06
Cancer cells are chameleons. They completely change their metabolism to grow continuously. University of Basel scientists have discovered that high levels of the amino acid arginine drive metabolic reprogramming to promote tumor growth. This study suggests new avenues to improve liver cancer treatment. The liver is a vital organ with many important functions in the body. It metabolizes nutrients, stores energy, regulates the blood sugar level and plays a crucial role in detoxifying and removing harmful components and drugs. Liver cancer is one of the world’s most lethal types of cancer. Conditions that cause liver cancer include obesity, excessive ...

Patterns in physician burnout

2023-10-06
About The Study: The findings of this survey study involving 1,373 physicians and three survey periods suggest that the physician burnout rate in the U.S. is increasing. This pattern represents a potential threat to the ability of the health care system to care for patients and needs urgent solutions.  Authors: Marcus V. Ortega, M.D., of Massachusetts General Hospital in Boston, is the corresponding author.   To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2023.36745) Editor’s Note: Please see the article for additional information, including ...

Rise in overdose deaths increasingly affects those with lower educational attainment, RAND study finds

2023-10-06
Drug overdose deaths increased sharply among Americans without a college education and nearly doubled over a three-year period among those who don’t have a high school diploma, according to a new RAND Corporation study. The findings further highlight a potential association between the rise in drug overdose deaths and barriers to education access, a social determinant of health.     Lower educational attainment has been one of the socioeconomic factors historically associated with drug use and overdose deaths, but the emergence of fentanyl in street drugs and the rise of the COVID-19 ...

Deciphering the intensity of past ocean currents

Deciphering the intensity of past ocean currents
2023-10-06
Details of past climate conditions are revealed to researchers not only by sediment samples from the ocean floor, but also by the surface of the seafloor, which is exposed to currents that are constantly altering it. Deposits shaped by near-bottom currents are called contourites. These sediment deposits contain information about past ocean conditions as well as clues to climate. Contourites are often found on continental slopes or around deep-sea mountains. But they can be found in any environment where strong currents occur near the seafloor. The mechanisms that control them are not yet well understood. ...

How bacteria can organize themselves

How bacteria can organize themselves
2023-10-06
In a recent study, scientists from the department Living Matter Physics at MPI-DS developed a model describing communication pathways in bacterial populations. Bacteria show an overall organizational pattern by sensing the concentration of chemicals in their environment and adapting their motion. The structure only becomes visible on a higher level “We modeled the non-reciprocal interaction between two bacterial species”, first author Yu Duan explains. “This means that species A is chasing species B, whereas B is aiming to repel from A”, he continues. The researchers found, that just this chase-and-avoid interaction is sufficient to form a structural pattern. The ...

Pulsars may make dark matter glow

2023-10-06
The central question in the ongoing hunt for dark matter is: what is it made of? One possible answer is that dark matter consists of particles known as axions. A team of astrophysicists, led by researchers from the universities of Amsterdam and Princeton, has now shown that if dark matter consists of axions, it may reveal itself in the form of a subtle additional glow coming from pulsating stars. Dark matter may be the most sought-for constituent of our universe. Surprisingly, this mysterious form of matter, ...

Researchers create a neural network for genomics—one that explains how it achieves accurate predictions

2023-10-06
A team of New York University computer scientists has created a neural network that can explain how it reaches its predictions. The work reveals what accounts for the functionality of neural networks—the engines that drive artificial intelligence and machine learning—thereby illuminating a process that has largely been concealed from users.  The breakthrough centers on a specific usage of neural networks that has become popular in recent years—tackling challenging biological questions. Among these are examinations of the intricacies of ...

LAST 30 PRESS RELEASES:

University of Tennessee, Lockheed Martin expand Master Research Agreement

Testing thousands of RNA enzymes helps find first ‘twister ribozyme’ in mammals

Groundbreaking study provides new evidence of when Earth was slushy

International survey of more than 1600 biomedical researchers on the perceived causes of irreproducibility of research results

Integrating data from different experimental approaches into one model is challenging – this study presents a community-based, full-scale in silico model of the rat hippocampal CA1 region that integra

SwRI awarded grant to characterize Las Moras Springs watershed

Water overuse in MATOPIBA could mean failure to meet up to 40% of local demand for crop irrigation

An extra year of education does not protect against brain aging

Researchers from Uppsala and Magdeburg obtain an ERC Synergy Grant to advance cancer immunotherapy

Deaf male mosquitoes don’t mate

Recognizing traumatic brain injury as a chronic condition fosters better care over the survivor’s lifetime

SwRI’s Dr. James Walker receives Distinguished Scientist Award from Hypervelocity Impact Society

A mother’s health problems pose a risk to her children

Ensuring a bright future for diamond electronics and sensors

The American Pediatric Society selects Dr. Maria Trent as the Recipient of the 2025 David G. Nichols Health Equity Award

The first 3D view of the formation and evolution of globular clusters

Towards a hydrogen-powered future: highly sensitive hydrogen detection system

Scanning synaptic receptors: A game-changer for understanding psychiatric disorders

High-quality nanomechanical resonators with built-in piezoelectricity

ERC Synergy Grants for 57 teams tackling major scientific challenges

Nordic research team receives €13 million to explore medieval book culture 

The origin of writing in Mesopotamia is tied to designs engraved on ancient cylinder seals

Explaining science through dance

Pioneering neuroendocrinologist's century of discovery launches major scientific tribute series

Gendered bilingualism in post-colonial Korea

Structural safety monitoring of buildings with color variations

Bio-based fibers could pose greater threat to the environment than conventional plastics

Bacteria breakthrough could accelerate mosquito control schemes

Argonne to help drive AI revolution in astronomy with new institute led by Northwestern University

Medicaid funding for addiction treatment hasn’t curbed overdose deaths

[Press-News.org] Clinical trials: two arms are better than one
In a comment to the EMA, IQWiG emphasizes that single-arm studies may be sufficient for drug approval in exceptional cases - but not for HTA. They hinder rather than accelerate improvements in health care